NSC |
Compound |
Enrichment |
Correlation |
NSC 703784 |
L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride |
0.00337662564965909 |
-0.0037869017 |
NSC 744688 |
Null |
0.00337662564965909 |
0.24493213 |
NSC 753456 |
2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole |
0.00337662564965909 |
0.21692558 |
NSC 742799 |
3-amino-N-(4-benzylphenyl)-1H-indazole-1-carboxamide |
0.00366577979610622 |
0.30590838 |
NSC 743227 |
2-chloro-1-[4-(4-chloro-1-cyclohexyl-2,5-dioxo-2,5-dihydro-1 H-3-pyrrolylamino)phenylcarboxamido]benzene |
0.00366577979610622 |
0.34319634 |
NSC 746035 |
2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone |
0.00366577979610622 |
0.36427031 |
NSC 9598 |
3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride |
0.00366577979610622 |
0.20217952 |
NSC 133072 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.00366577979610627 |
0.30567887 |
NSC 13317 |
Null |
0.00366577979610627 |
0.19396846 |
NSC 221266 |
Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy |
0.00366577979610627 |
0.31676634 |